|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales, general and administrative | |||||
| Amortization of intangibles | |||||
| Change in fair value of contingent consideration | |||||
| Certain litigation charges | |||||
| Impairment of goodwill | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair market value of warrants | |||||
| Other income (expense), net | |||||
| Gain on extinguishment of debt | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Changes in foreign currency translation adjustment | |||||
| Changes in unrealized gains (losses) on short-term investments, net | |||||
| Net change in other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of shares used to compute basic and diluted net income (loss) per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
